Prevention
Prevention
Paying for Health, Not Illness
Our models reveal the impacts of disease and the value of interventions that reduce disease and improve health and longevity.
Our Impact
Featured White Paper
Benefits of Medicare Coverage for Weight Loss Drugs
The cumulative social benefits from Medicare coverage for new obesity treatments over the next 10 years would reach almost $1 trillion, or roughly $100 billion per year.
Experts: Alison Sexton Ward, Bryan Tysinger, PhuongGiang Nguyen, Dana Goldman, Darius Lakdawalla
Top Prevention Stories View All
News
White House Move to Expand Obesity Drug Access Informed by Schaeffer Research
In The News View All
HealthDay
Avoiding sleep drugs could improve older Americans’ health and longevity, USC Schaeffer research shows
Featured Experts: Hanke Heun-Johnson, Jason Doctor
The Academic Minute
Chapel discusses his “diabetes paradox” research showing health gains haven’t led to labor gains among people with diabetes
Featured Experts: Jack M. Chapel
Bloomberg
Kanter interviewed on her research finding key vaccine committees had historically low levels of reported conflicts
Featured Experts: Genevieve P. Kanter
Associated Press
FDA’s use of ad hoc ‘expert panels’ may be used to legitimize predetermined views and create a false appearance of consensus, Kanter says
Featured Experts: Genevieve P. Kanter
Reuters
Kanter discusses the importance of vetting financial conflicts among CDC’s vaccine advisors
Featured Experts: Genevieve P. Kanter
Related Subtopics
Chronic diseases are among the most preventable and costliest conditions, consuming the overwhelming majority of Medicare resources. We assemble leading minds from across disciplines to address this challenge, striving to simplify labyrinthine systems of care and promote healthier outcomes.
Team View All Prevention Experts
